About Isaac Klein, M.D., Ph.D.
Isaac Klein, M.D., Ph.D. is a chief scientific officer and head of R&D at Dewpoint Therapeutics.
Isaac Klein, M.D., Ph.D. first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Isaac Klein, M.D., Ph.D. in the role, so the role may have started earlier or lasted longer.
Dewpoint Therapeutics, Inc.
Chief Scientific Officer and Head of R&D
2022 – 2026 · Boston, MA
Develops drug candidates for people with cancer and neurological diseases.
Key Colleagues at Startups
The people Isaac Klein, M.D., Ph.D. works with at each company, as listed on that company's latest Form D.
Dewpoint Therapeutics, Inc. · Form D/A, Jul 13, 2026
RD
Regina Barzilay, Ph.D.
Director
SD
Steven Neier, Ph.D.
Director
AD
Ameet Nathwani, M.D.
Chief Executive Officer and director
GD
Giuseppe Ciaramella, Ph.D.
Director
MD
Mark Murcko, Ph.D.
Director
SD
Srinivas Akkaraju, M.D., Ph.D.
Director
OD
Olivier Brandicourt, M.D.
Director
AD
Anthony Hyman, Ph.D.
Director
AD
Amir Nashat, Sc.D.
Director
RD
Richard Young, Ph.D.
Director